This test is a screen for Buprenorphone by immunoassay; if the screen is positive, this test automatically includes mass-spectrometry method quantitative confirmation for buprenorphine and its metabolite, norbuprenorphine. Quantitation/confirmation charged separately if needed. It is intended for use only in patients where an initial drug screening test has not already been performed (i.e. Point-of-Care drug screening cup, dipstick, etc.).
Buprenorphine is a member of the opioid family and is used as an alternative to methadone in the treatment of heroin addiction and as an analgesic for treatment of moderate to severe pain. Buprenorphine is metabolized to norbuprenorphine. Measurement of buprenorphine and norbuprenorphine assist the clinician in determining patient compliance with treatment.